|
| |
Red-Cell Aplasia PureDownload PDF containing detailed information.
Recent Publications on Red-Cell Aplasia Pure: |  |
End run around epo.
Many axonal growth inhibitors that contribute to the usual failure of axon... | 17th November, 2009
|
| N Engl J Med. 2009 Nov 5;361(19):1901-3.
DOI Direct Link |
A peptide-based erythropoietin-receptor agonist for pure red-cell aplasia.
BACKGROUND: We investigated whether a novel, synthetic, peptide-based... | 17th November, 2009
| Department of Renal Medicine, King's College Hospital, London.
| N Engl J Med. 2009 Nov 5;361(19):1848-55.
DOI Direct Link |
Resolution of pansclerotic morphea after treatment with antithymocyte globulin.
BACKGROUND: A previously healthy 50-year-old man presented with thickening... | 30th October, 2009
| Division of Rheumatology, Johns Hopkins University School of Medicine,
| Nat Rev Rheumatol. 2009 Sep;5(9):513-6.
DOI Direct Link |
Pure red cell precursor toxicity by linezolid in a pediatric case.
Linezolid (LZD)-induced myelosuppression has been reported in adults;... | 23rd September, 2009
| Division of Blood Transfusion, Shimane University Hospital, Izumo,
| J Pediatr Hematol Oncol. 2009 Sep;31(9):684-6.
DOI Direct Link |
[Pure red cell aplasia as first manifestation of primary Sjogren syndrome]
Pure red cell aplasia (PRCA) is a well-known marrow failure which may be... | 16th September, 2009
|
| Rev Clin Esp. 2009 Apr;209(4):203-4.
|
→View more research publications. |
Press Releases About Red-Cell Aplasia Pure:
|
 |
| Bioniche Strengthens the International Patent Portfolio for its MCC Technology Platform |
24th November, 2009 |
Bioniche Life Sciences Inc. |
-Japanese patent issuances facilitate commercialization of MCC in Japan-
BELLEVILLE, ON, Nov. 24 /PRNewswire-FirstCall/ - Bioniche Life Sciences Inc. (TSX: BNC), a research-based, technology-driven
|
| Ambit Biosciences Corporation Announces Presentations Profiling AC220 Clinical and Non-Clinical Data at 51st American Society of Hematology Annual Meeting |
24th November, 2009 |
Ambit Biosciences Corporation |
SAN DIEGO, Nov. 24 /PRNewswire/ -- Ambit Biosciences Corporation announced today that there will be multiple presentations evaluating AC220, a novel second generation FLT3 inhibitor, in AML at the
|
| Hard To Treat Diseases (HTDS) Exploration Of A 25 Billion Dollar Industry Regenerative Medicine and Stem Cell Bank Targeted Merger |
24th November, 2009 |
Hard to Treat Diseases |
BELGRADE, Serbia, Nov. 24 /PRNewswire-FirstCall/ - Hard to Treat Diseases (HTDS; http://www.htdsmedical.com/) and its operating subsidiary Slavica Bio Chem, is providing this brief update to its
|
| WellTek Positioned to Capitalize on Trends in Health and Fitness |
24th November, 2009 |
WellTek Incorporated |
ORLANDO, Fla., Nov. 24 /PRNewswire-FirstCall/ -- Two thirds of adults are overweight and one third of those are obese. Experts estimate that 80 percent of the population will experience a back
|
| Sundia MediTech Receives Red Herring Asia Top 100 Award |
24th November, 2009 |
Sundia MediTech Company |
SHANGHAI, Nov. 24 /PRNewswire-Asia/ -- Sundia MediTech Company, a leading
pharmaceutical R&D outsourcing service company in China, is proud to announce
that the company received the Red
|
BioPortfolio Ltd. offers e-mail and postal lists for Red-Cell Aplasia Pure scientists - we have details of around 110 individuals working on Red-Cell Aplasia Pure .
This page has been viewed 363 times
Recent Search Terms used to find this page: treatment for pure red cell aplasia in dogs | PRCA ONCOLOGY WIKI | pure red cell aplasia in dogs | pure red cell aplasia in dogs | ell aplasia wiki | Pure red cell aplasia secondary to carbamazepine | pure red cell aplasia in dogs | red cell aplasia in dogs | red cell aplasia in dogs | .
Browse BioPortfolio's InDepth service - alphabetically:
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
or by Most Publications, recently searched for, or
most viewed.
Search for Red-Cell Aplasia Pure across BioPortfolio, or for Red-Cell Aplasia Pure Research Reports
Wikipedia excerpt, where present, licenced under the GNU Free Documentation License. Resources from the NCBI applied. Selected MeSH subject headings created and maintained by the US NLM are used in conjunction with additional keywords. 2006-2008 MeSH.
Thumbshots from Thumbshots.org
|
